Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.34172/bi.2020.25 http://scihub22266oqcxt.onion/10.34172/bi.2020.25 32793443!7416005!32793443     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Bioimpacts 2020 ; 10 (3): 205-206 Nephropedia Template TP {{tp|p=32793443|t=2020. Computational-based drug repurposing methods in COVID-19 |pdf=|usr=}}{{32793443}} gab.com Text Computational-based drug repurposing methods in COVID-19 JO: Bioimpacts http://www.kidney.de/pget.php?&tw=1&pmid=32793443 #FOAvip COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19. Twit Text FOAVip Computational-based drug repurposing methods in COVID-19 ????Bioimpacts http://www.kidney.de/pget.php?&tw=1&pmid=32793443 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32793443 #FOAvip English Wikipedia <ref>{{Cite pmid|32793443}}</ref> Computational-based drug repurposing methods in COVID-19 #MMPMID32793443 Masoudi-Sobhanzadeh Y Bioimpacts 2020[]; 10 (3): 205-206 PMID32793443show ga COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19. äComputational-based drug repurposing methods in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing